AI Capital Risk Diagnostic

Request the AI Capital Risk Diagnostic

Use this form if you are evaluating whether to scale AI deployment capital beyond controlled pilots and need an authorization posture, ACRI score, and structural constraints in executive language.

The diagnostic answers whether to scale now, scale with constraints, or pause until risk is reduced. It is a board-level decision input, not a product trial.

Share a few details about your organization. We will follow up to confirm scope and next steps for evaluation and delivery.

No obligation. Confidential. Typically responds within 1 business day.

For context, see the diagnostic overview or the AI Capital Risk Benchmark Report (2026).

Confidential. No obligation.

We typically respond within one business day.

What you receive

  • Capital authorization posture (Pause, Controlled Investment, or Authorize Deployment)
  • AI Capital Risk Index (ACRI) aligned to the same evidence
  • Primary structural constraints to safe scale, in executive language
  • Stabilization and scale path sequenced to posture outcomes

Full evaluation through the AI Capital Risk Instrument (ACRI) includes the board-ready report and pathway. This request starts the same intake path with diagnostic intent flagged for routing.

Prefer a conversation first?

You can request an executive briefing instead if you want to align on scope before committing to diagnostic delivery.